Antidepressants can induce mutation and enhance persistence toward multiple antibiotics

Proc Natl Acad Sci U S A. 2023 Jan 31;120(5):e2208344120. doi: 10.1073/pnas.2208344120. Epub 2023 Jan 23.

Abstract

Antibiotic resistance is an urgent threat to global health. Antidepressants are consumed in large quantities, with a similar pharmaceutical market share (4.8%) to antibiotics (5%). While antibiotics are acknowledged as the major driver of increasing antibiotic resistance, little attention is paid to the contribution of antidepressants in this process. Here, we demonstrate that antidepressants at clinically relevant concentrations induce resistance to multiple antibiotics, even following short periods of exposure. Antibiotic persistence was also enhanced. Phenotypic and genotypic analyses revealed the enhanced production of reactive oxygen species following exposure to antidepressants was directly associated with increased resistance. An enhanced stress signature response and stimulation of efflux pump expression were also associated with increased resistance and persistence. Mathematical modeling also predicted that antidepressants would accelerate the emergence of antibiotic-resistant bacteria, and persister cells would help to maintain the resistance. Overall, our findings highlight the antibiotic resistance risk caused by antidepressants.

Keywords: antibiotic resistance; antidepressants; mutation; persistence.

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Antidepressive Agents* / pharmacology
  • Bacteria
  • Drug Resistance, Microbial
  • Mutation

Substances

  • Anti-Bacterial Agents
  • Antidepressive Agents